Long Non-coding RNA TLX1NB Regulates Inflammatory Response in Periodontitis by Interacting With Matrix Metalloproteinase 8 Authors: Shouxiang Yang, Wanting Yuan, Ziqiong Yang, Jiaxuan He, Xiaoqian Wang, Lei Lu, Zhijia Xu, Xiaoyu Yao, Chunai Zhan, Long Mei, Wanyu Zhang, Wei Shao, Xiaoyu Sun Published: 2026 ABSTRACT Long non-coding RNAs (lncRNAs) play critical roles in regulating inflammatory responses in periodontitis. This investigation focused on the involvement of the lncRNA T cell leukemia homeobox 1 neighbor (TLX1NB) in periodontitis and its regulatory role in modulating matrix metalloproteinase 8 (MMP8). Transcriptome sequencing and RT-qPCR validation revealed a significant upregulation of TLX1NB in gingival tissues from patients with periodontitis. This upregulation was recapitulated in an in vitro inflammatory model using TNF-α-stimulated human gingival fibroblasts (HGFs). Both FISH and cellular fractionation assays demonstrated that TLX1NB is predominantly enriched in the nucleus of HGFs. Functionally, TLX1NB knockdown attenuated the production of key pro-inflammatory cytokines, including IL-1β, IL-6, and IL-8, in TNF-α-stimulated HGFs, while concurrently enhancing cell proliferation. Mechanistically, RNA pull‑down and RIP assays confirmed a direct molecular interaction between TLX1NB and MMP8, suggesting that TLX1NB may regulate MMP8 function through direct binding. Functional analysis further demonstrated that TLX1NB and MMP8 act cooperatively to regulate inflammatory responses and apoptosis in HGFs. Ultimately, our results show that reducing TLX1NB expression alleviates periodontitis-associated inflammation and cellular dysfunction. This effect is associated with MMP8 and correlates with decreased NF-κB signaling. Collectively, these findings highlight TLX1NB as a promising therapeutic target for the treatment of periodontal disease.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1007/s10753-026-02541-3. Introduction Periodontitis is a long-term inflammatory condition caused by the immune system’s reaction to bacterial biofilms beneath the gums [1]. This disease process includes a series of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin (IL)-1β, and IL-6 [2]. Periodontitis is characterized by the breakdown of periodontal soft tissues, the loss of alveolar bone, and the possible loss of teeth [3]. Current therapeutic strategies primarily focus on removing bacterial plaque and suppressing inflammation [4]. However, the inherently limited regenerative capacity of damaged periodontal tissues often hinders complete functional recovery, thereby complicating clinical management [5]. Consequently, a deeper investigation into the molecular mechanisms underlying the pathogenesis and progression of periodontitis is crucial for the development of novel and effective therapeutic interventions. Long non-coding RNAs (lncRNAs), composed of over 200 nucleotides and without the ability to code for proteins, have become key regulators in a wide range of biological activities [6], including immune responses and inflammatory pathways [7, 8]. In periodontitis, growing evidence indicates that specific lncRNAs can modulate key pathogenic events [9], such as cytokine production (e.g., SNHG5 and MIR100HG), osteogenic differentiation (e.g., MALAT1 and POIR), and autophagy (e.g., H19) [10–14]. Nevertheless, the functional significance of the majority of differentially expressed lncRNAs in periodontitis remains largely unexplored. The lncRNA T cell leukemia homeobox 1 neighbor (TLX1NB), which is located adjacent to the TLX1 gene on chromosome 10q24.31, has garnered increasing research interest. Its recognized roles are primarily in the context of cancer, where it promotes STAT5A phosphorylation to facilitate the invasion, migration, and metastasis of colon cancer cells [15]. Due to its specific expression in tumor tissues, it has been proposed as a diagnostic biomarker for colorectal cancer and a recurrence marker for low-grade glioma [16, 17]. Notably, while its role in malignancies is recognized, its function in non-neoplastic inflammatory diseases, particularly in periodontitis, remains entirely unexplored. Matrix metalloproteinase 8 (MMP8), referred to as neutrophil collagenase [18], is a vital enzyme within the MMP family that degrades type I, II, and III collagens, significantly contributing to tissue remodeling and inflammatory responses [19]. In the pathological microenvironment of periodontitis, MMP8 is predominantly derived from infiltrating neutrophils and locally activated human gingival fibroblasts (HGFs) [20, 21]. Its activity not only directly drives the degradation of periodontal ligament collagen [22, 23] but also promotes alveolar bone resorption and amplifies local inflammatory responses [24, 25], thereby exacerbating tissue destruction. These properties establish MMP8 as a core effector molecule driving the loss of periodontal supporting tissues. MMP8 levels in both gingival crevicular fluid and saliva show a positive correlation with how severe the disease is, highlighting its role as a key biomarker in periodontitis [26, 27]. However, the detailed mechanism by which MMP8 regulates periodontitis is still under investigation. In this study, RNA sequencing of human gingival tissues revealed a significant upregulation of TLX1NB in periodontitis samples relative to healthy controls. This finding was further corroborated in TNF-α-stimulated HGFs by RT-qPCR. Both FISH and cellular fractionation assays demonstrated that TLX1NB is predominantly enriched in the nucleus of HGFs. Functional experiments demonstrate that TLX1NB knockdown attenuates the production of pro-inflammatory cytokines and enhances cell proliferation in TNF-α-stimulated HGFs. These effects are mechanistically linked to the direct interaction between TLX1NB and MMP8. This study provides the first evidence that TLX1NB contributes to periodontitis pathogenesis by cooperating with MMP8 to modulate inflammatory responses, which are associated with NF-κB signaling. By advancing mechanistic insights into lncRNAs in periodontitis, these results also highlight their translational potential as biomarkers for early prevention and personalized treatment. Materials and Methods Gingival Sample Collection Human gingival tissue specimens were obtained from 50 participants, comprising 30 healthy controls and 20 patients with periodontitis. Healthy controls were recruited from orthodontic patients undergoing surgical extraction of impacted teeth, with inclusion criteria of probing depth (PD) < 3 mm, no clinical attachment loss (CAL), and no radiographic evidence of alveolar bone resorption. Periodontitis patients met the inclusion criteria of PD > 6 mm, CAL > 3 mm, and radiographic alveolar bone resorption. Exclusion criteria for all participants included smoking, systemic diseases, recent systemic medication, previous periodontal therapy, and pregnancy [10]. Detailed inclusion and exclusion criteria are summarized in Appendix Table 1, and comprehensive clinical characteristics of all specimens are listed in Appendix Table 2. The Ethics Committee of Anhui Medical University granted ethical approval for the study protocol (Approval No. K2025002). Clinical trial number: not applicable. Isolation and Culture of HGFs Human gingival tissues were collected from orthodontic patients undergoing impacted tooth extraction (n = 10) at the Hospital of Stomatology, Anhui Medical University (Hefei, Anhui, China), with informed consent. During dissection, gingival tissues were carefully separated from the periodontal ligament, and only morphologically distinct gingival specimens were selected for cell isolation. The tissues were thoroughly rinsed with PBS containing 1% penicillin-streptomycin, minced into 1–2 mm³ explants, and cultured in αMEM supplemented with 20% fetal bovine serum (FBS). After 6 h, the culture medium was changed to αMEM supplemented with 10% FBS. Primary HGFs were passaged upon reaching 80% confluence. Hematoxylin and Eosin (H&E) Staining Following standard histological protocols, gingival tissue samples were processed through fixation with 4% paraformaldehyde, paraffin embedding, and sectioning. Tissue sections underwent sequential dewaxing, hydration, hematoxylin and eosin staining, dehydration, and mounting. Histopathological images were acquired using an Olympus microscope. Immunohistochemical Staining (IHC) Human gingival tissues were fixed, paraffin-embedded, and sectioned for immunohistochemical analysis. Following deparaffinization, antigen retrieval, and peroxidase inactivation, tissue sections were incubated with 5% normal goat serum (ZSGB-Biotech, Cat# ZLI-9022). Human samples were probed with antibodies against IL-1β (Cell Signaling Technology, Cat# 12242) and IL-6 (Proteintech, Cat# 21865-1-A), followed by incubation with appropriate secondary antibodies (Abcam, Cat# ab9704; Abcam, Cat# ab709) for 1 h. Diaminobenzidine (DAB) substrate (ZSGB-Biotech, Cat# ZLI-9017) was used to develop brown precipitates, and hematoxylin counterstaining was applied. We captured all images with an Olympus microscope. TNF-α Stimulation and Cell Transfection HGFs from passages 3–5 were plated in 6-well plates at 1 × 10⁵ cells/well and grown in αMEM containing 10% FBS. Upon reaching 80% confluence, these cells were used to investigate the role of TLX1NB under inflammatory conditions. To induce an inflammatory state, cells were exposed to 10 ng/mL TNF-α for 12 h prior to further experimental procedures. To elucidate the functional role of TLX1NB, siRNA and lentiviral systems were employed to achieve its knockdown and overexpression, respectively. The siRNA sequences were commercially sourced from Obio Technology (Shanghai, China), and lentiviral vectors were constructed by Shanghai Gene Pharma Co., Ltd. (Shanghai, China). To evaluate potential off-target effects, the siRNA/shRNA sequences were subjected to nucleotide BLAST search against the NCBI database following Ambion (Thermo Fisher) siRNA design guidelines. Those exhibiting ≥ 16 consecutive perfectly matched base pairs with any non-target human coding transcripts were excluded. This analysis confirmed 100% query coverage and 100% sequence identity to the intended targets, with no significant homology to any other known human transcripts. For siRNA transfection, HGFs were transfected using Lipofectamine 2000 (Invitrogen, Cat# 11668019) following the manufacturer’s instructions, with siRNAs applied at a final concentration of 50 nM. Detailed sequences are provided in Appendix Table 3. Lentiviral transduction was performed at a multiplicity of infection (MOI) of 20 with the addition of 5 µg/mL polybrene. After 24 h, the culture medium was refreshed to remove the viral supernatant. The transduction efficiency was assessed 72 h post-infection by quantifying green fluorescent protein (GFP)-positive cells using a fluorescence microscope (Yuescope, China). Detailed sequences are provided in Appendix Table 4. RNA Fluorescence in Situ Hybridization (FISH) To detect the subcellular distribution of TLX1NB in HGFs, FISH was employed. The TLX1NB-specific FISH probe was synthesized by RIBOBIO (Guangzhou, China). Following fixation, permeabilization, prehybridization, and overnight hybridization, the slides were sequentially washed, counterstained with DAPI (Beyotime, Cat# P0131), and imaged under a fluorescence microscope (Yuescope, China). Reverse Transcription Quantitative Polymerase Chain Reaction (RT-qPCR) Total RNA was extracted from cultured cells using the Goonie RNA Rapid Purification Kit (Goonie Biotech, Guangzhou, China). The extracted RNA was reverse transcribed into cDNA following the manufacturer’s instructions of the PrimeScript RT Reagent Kit (Takara, Kyoto, Japan). The synthesized cDNA was subjected to quantitative real-time PCR analysis with SYBR Green chemistry (Takara) and target-specific primers on a real-time PCR system. GAPDH served as the internal reference gene for data normalization. In addition, no-template controls were incorporated in each run to monitor potential contamination. Relative gene expression levels were calculated using the 2−ΔΔCt method. All primer sequences are listed in Appendix Table 5. Enzyme-Linked Immunosorbent Assay (ELISA) To assess the anti-inflammatory activity of TLX1NB, the levels of pro-inflammatory cytokines (IL-1β, IL-6, and IL-8) in the supernatant were quantified using commercial ELISA kits (Elabscience, Wuhan, China; Cat# EL-H0149, E-EL-H6156, and E-EL-H6008, respectively). After treatment, culture supernatants were harvested and clarified by centrifugation (12,000 × g, 20 min, 4 °C). Cytokine levels were subsequently quantified following the detailed protocols provided by each ELISA kit manufacturer. The absorbance readings were obtained with a microplate reader, and sample cytokine concentrations were interpolated from their respective standard curves. Cell Counting Kit-8 (CCK‑8) Cells were harvested by digestion, counted, and seeded into 96-well plates at a density of 4,000 cells per well. Plates were maintained in a standard incubator at 37 °C with 5% CO₂ and 90% humidity. After completion of the designated treatment course, 10 µl of CCK-8 reagent (Biosharp, Hefei, China) was dispensed into each well. The plates were then incubated for 2 h, followed by absorbance measurement at 450 nm using a microplate reader (BioTek, USA) for the quantification of cell viability. Flow Cytometric Analysis of Apoptosis Apoptosis was quantified by Annexin V-AbFluor™ 488/PI double staining on a flow cytometer (BD FACSCelesta™ Cell Analyzer) as recommended by the manufacturer (Abbkine, Cat# KTA0002). To avoid interference from the intrinsic GFP carried by the lentiviral vector, alternative experiments were conducted using the Annexin V-Alexa Fluor 647/7-AAD apoptosis detection kit (Bestbio, Cat# BB-41036), which uses an identical staining procedure. RNA Sequencing To delineate differentially expressed genes (DEGs) and enriched pathways in HGFs under inflammatory conditions, an integrated RNA sequencing analysis was performed using clinical specimens and in vitro validation. Periodontal tissues were obtained from eight independent individuals, including four healthy controls and four patients with periodontitis. For in vitro functional validation, HGFs transfected with negative control (si-NC) or TLX1NB-knockdown (si-TLX1NB) constructs were stimulated with TNF-α for 12 h. All experiments were performed in at least three biological replicates. Following total RNA extraction with TRIzol and quality assessment, sequencing libraries were constructed and sequenced on an Illumina NovaSeq 6000 platform by OE Biotech (Shanghai, China) and Gene Denovo (Guangzhou, China). After preprocessing raw reads with fastp (v0.18.0), transcripts were assembled and aligned using StringTie (v1.3.1) in reference-based mode, and gene expression was quantified as FPKM values using RSEM. Differential expression analysis was performed with DESeq2, applying the following significance thresholds: in clinical samples, |fold change| > 2 and FDR < 0.05; in HGFs, |fold change| > 1.5 and FDR < 0.05. Statistically significant GO terms and KEGG pathways were identified with a corrected p-value < 0.05. Western Blot The expression levels of target signaling molecules, including NF-κB p65, were evaluated via Western blot analysis. HGFs were collected and lysed in RIPA lysis buffer (Solabio, Cat# R0010) supplemented with a cocktail of protease and phosphatase inhibitors (Beyotime, Cat# P1045). After total protein extraction, protein concentrations were determined using an enhanced BCA protein assay kit (Beyotime, Cat# P0010). Separated proteins were then electrotransferred onto polyvinylidene fluoride (PVDF) membranes, with immunoreactive bands visualized using a highly sensitive ECL chemiluminescent substrate (NCM Biotech, Cat# P2200). Detailed antibodies are provided in Appendix Table 6. RNA Pull-down Assay Biotin-labeled antisense and sense lncRNA probes were designed, synthesized, and validated by Geneseed Biotech (Guangzhou, China). The probes were generated by in vitro transcription and immobilized onto streptavidin-coupled magnetic beads, with the sense probe serving as a negative control. The RNA-bound beads were then incubated overnight at 4 °C with whole-cell lysates prepared from HGFs. After extensive washing with RIPA buffer, the captured protein complexes were eluted by boiling in SDS loading buffer and subjected to Western blotting using an anti-MMP8 antibody. Detailed antibody information is provided in Appendix Table 6. RNA Immunoprecipitation (RIP) Assay RIP was performed to investigate the interaction between TLX1NB and MMP8. HGFs were lysed using RIP lysis buffer on ice for 30 min. Following centrifugation, the cleared supernatant was collected. Protein A + G Magnetic Beads (Beyotime, Cat# P2179M) were coated with anti-MMP8 antibody or control IgG overnight at 4 °C. The whole-cell lysates were then incubated with RIP buffer containing the antibody-coated beads overnight. Subsequently, the immunoprecipitated RNAs were isolated from the precipitates and subjected to RT-qPCR analysis. Statistical Analysis Statistical analyses were conducted using GraphPad Prism (version 8.0.2). Quantitative data from at least three independent experiments are expressed as mean ± standard deviation (SD). For comparisons between two groups, Student’s t-test was employed. For comparisons among multiple groups, one-way ANOVA was used, followed by Tukey’s HSD post-hoc test when data met normality and homogeneity of variances, or Welch’s ANOVA with Games-Howell test when variances were unequal. A p-value of less than 0.05 was considered statistically significant. Results LncRNA TLX1NB is Upregulated in Periodontitis Tissues and Inflammatory HGFs To identify lncRNAs implicated in the pathogenesis of periodontitis, we performed RNA sequencing on gingival tissues from 4 patients with periodontitis and 4 healthy controls. The analysis identified 1,226 differentially expressed lncRNAs, with 679 upregulated and 547 downregulated. Among these, TLX1NB emerged as one of the significantly upregulated transcripts in the diseased tissues (Fig. 1a). H&E and IHC staining indicated pronounced inflammatory cell infiltration in periodontitis samples (Fig. 1b), consistent with increased transcript levels of IL-1β, IL-6, IL-8, and TNF-α measured by RT-qPCR (Fig. 1c). TLX1NB upregulation in periodontitis-affected gingiva was confirmed by RT-qPCR (Fig. 1d). Fig. 1LncRNA TLX1NB is upregulated in the gingival tissues of periodontitis patients and in TNF-α-stimulated human HGFs (a) Volcano plot showing differentially expressed lncRNAs in gingival tissues from periodontitis patients (n = 4) and healthy controls (n = 4). Significantly dysregulated lncRNAs (FDR < 0.05) are highlighted (red: upregulated; blue: downregulated). (b) Representative images of H&E staining and IHC detection of IL-1β and IL-6 in gingival tissues from healthy subjects and periodontitis patients. Scale bar = 100 μm. (c) RT-qPCR analysis of proinflammatory cytokines (IL-1β, IL-6, IL-8, and TNF-α) in gingival tissues from healthy controls (n = 12) and periodontitis patients (n = 12). (d) Relative TLX1NB mRNA expression in gingival tissues from healthy individuals (n = 12) and periodontitis patients (n = 12). (e) Time-dependent changes in TLX1NB mRNA expression in HGFs treated with TNF-α for 0–24 h, showing a transient induction. (f) Expression of IL-1β, IL-6, and IL-8 mRNAs significantly increased after 12 h of TNF-α stimulation compared with controls. (g) Subcellular fractionation showing predominant nuclear localization of TLX1NB in HGFs under control and TNF-α–stimulated conditions. GAPDH and U6 served as cytoplasmic and nuclear markers, respectively. (h) FISH confirms nuclear localization of TLX1NB (red) in HGFs. U6 and 18 S were used as nuclear and cytoplasmic controls, respectively. Scale bar = 25 μm. Statistical differences between the two groups were analyzed via the unpaired Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001; ns, no significant difference LncRNA TLX1NB is upregulated in the gingival tissues of periodontitis patients and in TNF-α-stimulated human HGFs (a) Volcano plot showing differentially expressed lncRNAs in gingival tissues from periodontitis patients (n = 4) and healthy controls (n = 4). Significantly dysregulated lncRNAs (FDR < 0.05) are highlighted (red: upregulated; blue: downregulated). (b) Representative images of H&E staining and IHC detection of IL-1β and IL-6 in gingival tissues from healthy subjects and periodontitis patients. Scale bar = 100 μm. (c) RT-qPCR analysis of proinflammatory cytokines (IL-1β, IL-6, IL-8, and TNF-α) in gingival tissues from healthy controls (n = 12) and periodontitis patients (n = 12). (d) Relative TLX1NB mRNA expression in gingival tissues from healthy individuals (n = 12) and periodontitis patients (n = 12). (e) Time-dependent changes in TLX1NB mRNA expression in HGFs treated with TNF-α for 0–24 h, showing a transient induction. (f) Expression of IL-1β, IL-6, and IL-8 mRNAs significantly increased after 12 h of TNF-α stimulation compared with controls. (g) Subcellular fractionation showing predominant nuclear localization of TLX1NB in HGFs under control and TNF-α–stimulated conditions. GAPDH and U6 served as cytoplasmic and nuclear markers, respectively. (h) FISH confirms nuclear localization of TLX1NB (red) in HGFs. U6 and 18 S were used as nuclear and cytoplasmic controls, respectively. Scale bar = 25 μm. Statistical differences between the two groups were analyzed via the unpaired Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001; ns, no significant difference To simulate the inflammatory microenvironment of periodontitis in vitro, we employed TNF-α to stimulate HGFs (culture and identification data shown in Appendix Figure S1a, b) [28]. TNF-α acts as a pivotal mediator of periodontal inflammation and alveolar bone resorption. Thus, it is widely used to establish inflammatory models [29, 30]. Time-course analysis indicated that TNF-α induced a transient upregulation of TLX1NB, peaking at 12 h (Fig. 1e). The elevation of TLX1NB occurred prior to or concurrently with the induction of IL-1β, IL-6, and IL-8 (Fig. 1f, Appendix Figure S2a, b), suggesting its involvement in the early inflammatory response. To determine its functional compartmentalization, we next investigated the subcellular distribution of TLX1NB. Both FISH and cellular fractionation assays unequivocally demonstrated that TLX1NB is predominantly enriched in the nucleus of HGFs, and this nuclear localization was not significantly altered by TNF-α stimulation (Fig. 1g, h). This finding suggests that TLX1NB may function through a mechanism that regulates nuclear events. TLX1NB Knockdown Attenuates TNF-α-Induced Inflammation and Apoptosis While Promoting Proliferation in HGFs To investigate the functional role of TLX1NB in HGFs under inflammatory conditions, we knocked down TLX1NB using specific siRNA and lentiviral shRNA. Successful lentiviral transduction was confirmed by fluorescence microscopy 72 h post-transfection (Fig. 2a), and RT-qPCR analysis verified a significant knockdown efficiency of TLX1NB in shTLX1NB-treated cells compared to the shNC control (Fig. 2b). While TNF-α treatment markedly elevated the mRNA levels of IL-1β, IL-6, and IL-8 in control HGFs, the knockdown of TLX1NB substantially blunted this pro-inflammatory response (Fig. 2c-e). Consistent with these findings, transfection with siRNA targeting TLX1NB (si-TLX1NB) recapitulated the anti-inflammatory effects, further confirming the specificity and reproducibility of the observed phenotype (Fig. 2f-i). Given that si-TLX1NB-3 exhibited the highest knockdown efficiency, it was selected for all subsequent functional experiments. Fig. 2Knockdown of TLX1NB attenuates inflammatory response and apoptosis while enhancing proliferation in TNF-α-stimulated HGFs. (a) Representative fluorescence microscopy images of HGFs transduced with lentivirus carrying negative control (LV-shNC) or TLX1NB-targeting shRNAs (LV-shTLX1NB-1, LV-shTLX1NB-2) for 72 h. Scale bar = 200 μm. (b) RT-qPCR validation of TLX1NB knockdown efficiency in HGFs following lentiviral transduction. (c-e) RT-qPCR analysis showing mRNA expression of IL-1β, IL-6, and IL-8 in HGFs after TLX1NB knockdown under TNF-α stimulation. (f) RT-qPCR confirmation of TLX1NB knockdown efficiency in HGFs transfected with siRNAs (si-NC, si-TLX1NB-1, si-TLX1NB-2, si-TLX1NB-3). (g-i) RT-qPCR analysis of IL-1β, IL-6, and IL-8 mRNA expression in HGFs after TLX1NB silencing under TNF-α stimulation. (j-l) ELISA assays showing reduced secretion of IL-1β, IL-6, and IL-8 in TLX1NB-silenced HGFs after TNF-α treatment. (m) Representative flow cytometry plots demonstrating the effect of TLX1NB silencing on apoptosis of HGFs following TNF-α stimulation. (n) Quantification of apoptotic cells based on flow cytometry analysis. (o) CCK-8 assay showing enhanced cell proliferation in TLX1NB-silenced HGFs under both basal and TNF-α-stimulated conditions. Statistical differences between the two groups were analyzed via the unpaired Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001; ns, no significant difference Knockdown of TLX1NB attenuates inflammatory response and apoptosis while enhancing proliferation in TNF-α-stimulated HGFs. (a) Representative fluorescence microscopy images of HGFs transduced with lentivirus carrying negative control (LV-shNC) or TLX1NB-targeting shRNAs (LV-shTLX1NB-1, LV-shTLX1NB-2) for 72 h. Scale bar = 200 μm. (b) RT-qPCR validation of TLX1NB knockdown efficiency in HGFs following lentiviral transduction. (c-e) RT-qPCR analysis showing mRNA expression of IL-1β, IL-6, and IL-8 in HGFs after TLX1NB knockdown under TNF-α stimulation. (f) RT-qPCR confirmation of TLX1NB knockdown efficiency in HGFs transfected with siRNAs (si-NC, si-TLX1NB-1, si-TLX1NB-2, si-TLX1NB-3). (g-i) RT-qPCR analysis of IL-1β, IL-6, and IL-8 mRNA expression in HGFs after TLX1NB silencing under TNF-α stimulation. (j-l) ELISA assays showing reduced secretion of IL-1β, IL-6, and IL-8 in TLX1NB-silenced HGFs after TNF-α treatment. (m) Representative flow cytometry plots demonstrating the effect of TLX1NB silencing on apoptosis of HGFs following TNF-α stimulation. (n) Quantification of apoptotic cells based on flow cytometry analysis. (o) CCK-8 assay showing enhanced cell proliferation in TLX1NB-silenced HGFs under both basal and TNF-α-stimulated conditions. Statistical differences between the two groups were analyzed via the unpaired Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001; ns, no significant difference At the protein level, ELISA showed that TLX1NB knockdown counteracted TNF-α-induced cytokine release (Fig. 2j-l). Functionally, flow cytometric analysis revealed that TLX1NB knockdown significantly reduced TNF-α-induced apoptosis (Fig. 2m, n). Moreover, CCK-8 assays indicated that TLX1NB-deficient cells exhibited enhanced proliferative capacity compared to controls (Fig. 2o). Collectively, these data indicate that TLX1NB knockdown not only mitigates inflammation but also confers resistance to apoptosis and promotes proliferation in HGFs under inflammatory stress. TLX1NB Overexpression Exacerbates TNF-α-Induced Inflammatory Response and Apoptosis While Suppressing Proliferation in HGFs To functionally validate these observations, we next determined whether TLX1NB overexpression could aggravate the inflammatory and apoptotic phenotypes in HGFs. Following successful lentiviral-mediated overexpression, as confirmed by fluorescence microscopy and quantitative RT-qPCR (Fig. 3a, b), we evaluated its functional consequences under inflammatory conditions. TLX1NB overexpression in TNF-α-treated HGFs not only amplified the transcription of IL-1β, IL-6, and IL-8 (Fig. 3c-e) but also augmented their extracellular release, as evidenced by elevated protein concentrations in the supernatant (Fig. 3f-h). Fig. 3Overexpression of TLX1NB enhances inflammatory response and apoptosis while suppressing proliferation in TNF-α-stimulated HGFs (a) Representative fluorescence microscopy images of HGFs at 72 h post-lentiviral transduction. Scale bar, 200 μm. (b) RT-qPCR validated the overexpression efficiency of TLX1NB in HGFs. NC-OE, negative control overexpression group; TLX1NB-OE, TLX1NB overexpression group. (c-e) RT-qPCR analysis of the mRNA expression levels of inflammatory cytokines IL-1β, IL-6, and IL-8 in HGFs upon TNF-α stimulation with or without TLX1NB overexpression. (f-h) ELISA analysis of the secretion levels of inflammatory cytokines IL-1β, IL-6, and IL-8 in HGF supernatants upon TNF-α stimulation under the condition of TLX1NB overexpression. (i) Representative flow cytometry plots demonstrating the effect of TLX1NB overexpression on apoptosis of HGFs following TNF-α stimulation. (j) Quantitative analysis of apoptotic cells based on flow cytometry. (k) Cell proliferation was evaluated by CCK-8 assay in HGFs with or without TLX1NB overexpression. Statistical differences between the two groups were analyzed via the unpaired Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001; ns, no significant difference Overexpression of TLX1NB enhances inflammatory response and apoptosis while suppressing proliferation in TNF-α-stimulated HGFs (a) Representative fluorescence microscopy images of HGFs at 72 h post-lentiviral transduction. Scale bar, 200 μm. (b) RT-qPCR validated the overexpression efficiency of TLX1NB in HGFs. NC-OE, negative control overexpression group; TLX1NB-OE, TLX1NB overexpression group. (c-e) RT-qPCR analysis of the mRNA expression levels of inflammatory cytokines IL-1β, IL-6, and IL-8 in HGFs upon TNF-α stimulation with or without TLX1NB overexpression. (f-h) ELISA analysis of the secretion levels of inflammatory cytokines IL-1β, IL-6, and IL-8 in HGF supernatants upon TNF-α stimulation under the condition of TLX1NB overexpression. (i) Representative flow cytometry plots demonstrating the effect of TLX1NB overexpression on apoptosis of HGFs following TNF-α stimulation. (j) Quantitative analysis of apoptotic cells based on flow cytometry. (k) Cell proliferation was evaluated by CCK-8 assay in HGFs with or without TLX1NB overexpression. Statistical differences between the two groups were analyzed via the unpaired Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001; ns, no significant difference We next asked whether the pro-inflammatory function of TLX1NB was associated with changes in cell viability and proliferation. To avoid interference from the intrinsic GFP carried by the lentiviral vector, we performed flow cytometric analysis using the Annexin V-Alexa Fluor 647/7-AAD apoptosis detection kit. Flow cytometry showed that TLX1NB overexpression augmented TNF-α-induced apoptosis (Fig. 3i, j). In addition, CCK-8 proliferation assays revealed that ectopic TLX1NB expression significantly inhibited cell proliferation (Fig. 3k). Taken together, these results demonstrate that TLX1NB not only potentiates the TNF-α-driven inflammatory cascade but also exacerbates apoptosis and restricts proliferation, thereby underscoring its role as a critical regulator of cellular homeostasis in periodontal inflammation. TLX1NB Regulates MMP8 to Modulate Inflammation, Apoptosis, and Proliferation in HGFs To elucidate the specific role of TLX1NB in HGFs under inflammatory conditions, we performed RNA sequencing to profile DEGs in TNF-α-stimulated HGFs following TLX1NB knockdown. Volcano plot analysis revealed 500 significantly altered genes, with 172 upregulated and 328 downregulated in si-TLX1NB-treated HGFs compared to controls (Fig. 4a, Appendix Table 7). Analysis of KEGG pathways revealed that pathways including cell cycle, p53 signaling, and cellular senescence were significantly enriched, underscoring the diverse regulatory roles of TLX1NB (Fig. 4b). Complementing this, GO enrichment analysis indicated that TLX1NB knockdown profoundly impacted biological processes, particularly those associated with cell cycle regulation, mitosis, and nuclear division (Fig. 4c). Fig. 4Integrated transcriptome profiling identifies MMP8 as a core regulatory molecule cooperating with TLX1NB to modulate HGFs function under inflammatory conditions (a) Volcano plot depicting the transcriptome-wide gene expression changes. Genes with significant differential expression (FDR < 0.05) are highlighted in red (upregulated) and blue (downregulated). (b, c) Top 10 significantly enriched KEGG pathways and GO biological processes of differentially expressed genes in TNF-α-stimulated HGFs upon TLX1NB knockdown. (d) Relative MMP8 mRNA expression in gingival tissues from healthy individuals (n = 10) and periodontitis patients (n = 10). (e) IHC detection of MMP8 in gingival tissues from healthy subjects and periodontitis patients. Scale bar = 100 μm. (f) RNA pull-down assay verified the specific interaction between TLX1NB and MMP8. Biotin-labeled antisense TLX1NB, but not the sense probe, precipitated endogenous MMP8 protein. (g) RIP-qPCR assay demonstrating specific enrichment of TLX1NB by MMP8. Anti-MMP8 antibody, but not the IgG control, significantly enriched TLX1NB transcripts in HGFs. (h) RT-qPCR analysis of the mRNA expression levels of inflammatory cytokines IL-1β, IL-6, and IL-8 in TNF-α-stimulated HGFs upon MMP8 knockdown. (i) Representative flow cytometry plots demonstrating the effect of MMP8 knockdown on apoptosis of HGFs following TNF-α stimulation. (j) Quantitative analysis of apoptotic cells based on flow cytometry. (k) Cell proliferation assessed by CCK-8 assay in TNF-α-stimulated HGFs following MMP8 knockdown. Statistical differences between the two groups were analyzed via the unpaired Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001; ns, no significant difference Integrated transcriptome profiling identifies MMP8 as a core regulatory molecule cooperating with TLX1NB to modulate HGFs function under inflammatory conditions (a) Volcano plot depicting the transcriptome-wide gene expression changes. Genes with significant differential expression (FDR < 0.05) are highlighted in red (upregulated) and blue (downregulated). (b, c) Top 10 significantly enriched KEGG pathways and GO biological processes of differentially expressed genes in TNF-α-stimulated HGFs upon TLX1NB knockdown. (d) Relative MMP8 mRNA expression in gingival tissues from healthy individuals (n = 10) and periodontitis patients (n = 10). (e) IHC detection of MMP8 in gingival tissues from healthy subjects and periodontitis patients. Scale bar = 100 μm. (f) RNA pull-down assay verified the specific interaction between TLX1NB and MMP8. Biotin-labeled antisense TLX1NB, but not the sense probe, precipitated endogenous MMP8 protein. (g) RIP-qPCR assay demonstrating specific enrichment of TLX1NB by MMP8. Anti-MMP8 antibody, but not the IgG control, significantly enriched TLX1NB transcripts in HGFs. (h) RT-qPCR analysis of the mRNA expression levels of inflammatory cytokines IL-1β, IL-6, and IL-8 in TNF-α-stimulated HGFs upon MMP8 knockdown. (i) Representative flow cytometry plots demonstrating the effect of MMP8 knockdown on apoptosis of HGFs following TNF-α stimulation. (j) Quantitative analysis of apoptotic cells based on flow cytometry. (k) Cell proliferation assessed by CCK-8 assay in TNF-α-stimulated HGFs following MMP8 knockdown. Statistical differences between the two groups were analyzed via the unpaired Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001; ns, no significant difference To identify key downstream effectors of TLX1NB, we prioritized the top DEGs and validated the expression using RT-qPCR (Appendix Figure S3a-f). We next focused on MMP8, a well-characterized collagenase that plays a critical role in the pathogenesis of periodontitis and acts as a key effector driving periodontal tissue destruction [24, 26, 27]. Beyond degrading the extracellular matrix, it also processes cytokines and chemokines, thereby amplifying the inflammatory cascade, a central process in periodontitis pathogenesis [31, 32]. In human gingival tissues, MMP8 mRNA and protein levels were significantly higher in periodontitis patients than in healthy controls (Fig. 4d, e). To explore the molecular mechanism by which TLX1NB regulates MMP8 expression, we performed RNA pull-down assays. The results demonstrated that biotin-labeled TLX1NB probes specifically precipitated endogenous MMP8 protein compared with negative control probes (Fig. 4f). Subsequent RIP‑qPCR analysis further confirmed that anti‑MMP8 antibody immunoprecipitation significantly enriched TLX1NB transcripts in HGFs compared with IgG control (Fig. 4g). To dissect this functional relationship, we transfected HGFs with MMP8-targeting siRNA and verified efficient knockdown via RT-qPCR (Appendix Figure S4). Silencing MMP8 significantly attenuated the TNF-α-induced upregulation of pro-inflammatory cytokines (IL-1β, IL-6, and IL-8) at the transcriptional level in HGFs (Fig. 4h). Furthermore, flow cytometry and CCK-8 assays revealed that MMP8 knockdown attenuated TNF-α-induced apoptosis and restored cellular proliferation (Figs. 4i-k). Collectively, these findings establish MMP8 as a pivotal mediator in periodontitis pathogenesis, whose expression is governed by TLX1NB. TLX1NB and MMP8 Are Associated with NF-κB Signaling Activation in HGFs In line with the established function of NF-κB signaling in inflammatory responses and previous findings associating MMP8 with this pathway in periodontitis [31–33], this study further investigated whether the regulatory relationship between TLX1NB and MMP8 is associated with NF-κB activation. Western blot analysis showed that MMP8 knockdown in TNF-α-treated HGFs significantly reduced the phosphorylation of p65 (pp65) and IκB-α (pIκB-α), compared to the scramble control (Fig. 5a-c). Fig. 5TLX1NB and MMP8 regulate the activation of the NF-κB signaling pathway in HGFs under inflammatory stress (a) Western blot analysis and quantitative results showing the protein levels of phosphorylated p65 (pp65) and phosphorylated IκB-α (pIκB-α) in TNF-α-stimulated HGFs transfected with si-MMP8 or si-NC. (b, c) Quantitative densitometric analysis of the presented as the ratio of pp65 to total p65 and pIκB-α to total IκB-α. (d) Western blot analysis and quantitative results showing the protein levels of pp65 and pIκB-α in TNF-α-stimulated HGFs transfected with si-TLX1NB or si-NC. (e, f) Quantitative analysis showing the pp65/p65 ratio and pIκB-α/IκB-α ratio. (g) Western blot analysis and quantitative results demonstrating the effect of TLX1NB overexpression on the phosphorylation of p65 and IκB-α in TNF-α-stimulated HGFs. (h, i) Quantitative analysis of depicting the pp65/p65 ratio and pIκB-α/IκB-α ratio. Statistical differences between the two groups were analyzed via the unpaired Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001; ns, no significant difference TLX1NB and MMP8 regulate the activation of the NF-κB signaling pathway in HGFs under inflammatory stress (a) Western blot analysis and quantitative results showing the protein levels of phosphorylated p65 (pp65) and phosphorylated IκB-α (pIκB-α) in TNF-α-stimulated HGFs transfected with si-MMP8 or si-NC. (b, c) Quantitative densitometric analysis of the presented as the ratio of pp65 to total p65 and pIκB-α to total IκB-α. (d) Western blot analysis and quantitative results showing the protein levels of pp65 and pIκB-α in TNF-α-stimulated HGFs transfected with si-TLX1NB or si-NC. (e, f) Quantitative analysis showing the pp65/p65 ratio and pIκB-α/IκB-α ratio. (g) Western blot analysis and quantitative results demonstrating the effect of TLX1NB overexpression on the phosphorylation of p65 and IκB-α in TNF-α-stimulated HGFs. (h, i) Quantitative analysis of depicting the pp65/p65 ratio and pIκB-α/IκB-α ratio. Statistical differences between the two groups were analyzed via the unpaired Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001; ns, no significant difference Also, TLX1NB silencing recapitulated the inhibitory effect of MMP8 knockdown, reducing p65 and IκB-α phosphorylation in TNF-α-stimulated HGFs, mirroring the MMP8 depletion phenotype (Fig. 5d-f). Conversely, TLX1NB overexpression in TNF-α-treated HGFs amplified NF-κB activation, as shown by Western blotting (Fig. 5g-i). Demonstrated significantly elevated phosphorylation levels of p65 and IκB-α compared to the empty vector control. TLX1NB and MMP8 Synergistically Regulate TNF-α-Induced Inflammatory Response in HGFs To further determine whether TLX1NB and MMP8 function cooperatively in regulating inflammatory responses, we performed dual gene silencing experiments in HGFs. Concurrent knockdown of TLX1NB and MMP8 resulted in a more pronounced suppression of TNF-α-induced pro-inflammatory cytokine expression at the transcriptional level compared to individual gene silencing, as evidenced by RT-qPCR analysis of IL-1β and IL-6 (Fig. 6a, b). This enhanced anti-inflammatory effect was consistently observed at the protein level, with ELISA revealing a significantly greater reduction in cytokine secretion in double-knockdown cells than in either single-knockdown group (Fig. 6c, d, Appendix Figure S5). Fig. 6Co-silencing of TLX1NB and MMP8 synergistically suppresses TNF-α-driven pro-inflammatory cytokine secretion and apoptosis in human gingival fibroblasts (a, b) RT-qPCR analysis of the mRNA expression levels of inflammatory cytokines IL-1β and IL-6 in HGFs under TNF-α stimulation following individual or combined knockdown of TLX1NB and MMP8. (c, d) ELISA measuring the secretion levels of inflammatory cytokines IL-1β and IL-6 in the culture supernatant of HGFs under the indicated conditions. (e) Representative flow cytometry plots showing apoptosis of HGFs with or without TNF-α stimulation upon individual or combined knockdown of TLX1NB and MMP8. (f) Quantitative analysis of apoptotic cells based on flow cytometry. (g, h) RT-qPCR analysis of IL-1β and IL-6 mRNA expression in HGFs with or without TNF-α stimulation following individual or combined treatment with TLX1NB knockdown and/or MMP8 overexpression. Multiple group comparisons used one-way ANOVA. Tukey’s HSD post-hoc test was applied for data with normality and homogeneity of variances, while Welch’s ANOVA with the Games-Howell test was used for data with unequal variances. *P < 0.05, **P < 0.01, ***P < 0.001; ns, no significant difference Co-silencing of TLX1NB and MMP8 synergistically suppresses TNF-α-driven pro-inflammatory cytokine secretion and apoptosis in human gingival fibroblasts (a, b) RT-qPCR analysis of the mRNA expression levels of inflammatory cytokines IL-1β and IL-6 in HGFs under TNF-α stimulation following individual or combined knockdown of TLX1NB and MMP8. (c, d) ELISA measuring the secretion levels of inflammatory cytokines IL-1β and IL-6 in the culture supernatant of HGFs under the indicated conditions. (e) Representative flow cytometry plots showing apoptosis of HGFs with or without TNF-α stimulation upon individual or combined knockdown of TLX1NB and MMP8. (f) Quantitative analysis of apoptotic cells based on flow cytometry. (g, h) RT-qPCR analysis of IL-1β and IL-6 mRNA expression in HGFs with or without TNF-α stimulation following individual or combined treatment with TLX1NB knockdown and/or MMP8 overexpression. Multiple group comparisons used one-way ANOVA. Tukey’s HSD post-hoc test was applied for data with normality and homogeneity of variances, while Welch’s ANOVA with the Games-Howell test was used for data with unequal variances. *P < 0.05, **P < 0.01, ***P < 0.001; ns, no significant difference We further investigated whether this synergistic regulation extended to cellular fate decisions. Flow cytometric analysis demonstrated that combined TLX1NB and MMP8 knockdown produced a more substantial reduction in TNF-α-induced apoptosis than individual knockdowns (Fig. 6e, f). Collectively, our findings provide compelling evidence that TLX1NB and MMP8 function synergistically in modulating the inflammatory response and cellular apoptosis in HGFs. Having established their cooperative function, we next sought to determine the causal relationship between TLX1NB and MMP8. To this end, we first validated that MMP8 overexpression efficiently upregulated MMP8 mRNA levels (Appendix Figure S6). Subsequently, we performed rescue experiments combining TLX1NB knockdown with MMP8 overexpression. Knockdown of TLX1NB alone significantly downregulated the mRNA expression of both IL-1β and IL-6, whereas MMP8 overexpression alone markedly upregulated their levels. Importantly, the downregulation of IL-1β and IL-6 induced by TLX1NB knockdown was substantially reversed by MMP8 overexpression (Fig. 6g, h). These rescue experiments support a causal model in which TLX1NB acts, at least in part, through regulating MMP8 to promote inflammatory responses. Discussion LncRNAs have emerged as pivotal epigenetic regulators in inflammatory diseases, with accumulating evidence linking their dysregulation to periodontitis progression [9, 33]. The current study identifies lncRNA TLX1NB as a novel pro-inflammatory mediator in periodontitis, revealing that it potentiates inflammatory reactions in HGFs, and this effect involves MMP8 and is associated with NF-κB signaling (Fig. 7). These observations broaden the identified functional landscape of lncRNA TLX1NB and offer fresh insights into periodontal disease development and progression. Fig. 7Schematic illustration of the regulatory mechanism of TLX1NB and MMP8 in the NF-κB signaling pathway in HGFs. Upon TNF-α stimulation, the expression level of TLX1NB in HGFs is markedly upregulated. TLX1NB subsequently interacts with MMP8. This interaction is associated with the nuclear translocation of the p65-p50 dimer and the activation of the NF-κB signaling pathway. This activation leads to the enhanced transcription of pro-inflammatory cytokines, including IL-1β, IL-6, and IL-8, thereby amplifying the inflammatory response. Within this regulatory framework, TLX1NB plays a pivotal role in mediating TNF-α-induced inflammatory responses in HGFs by modulating MMP8 expression and NF-κB signaling Schematic illustration of the regulatory mechanism of TLX1NB and MMP8 in the NF-κB signaling pathway in HGFs. Upon TNF-α stimulation, the expression level of TLX1NB in HGFs is markedly upregulated. TLX1NB subsequently interacts with MMP8. This interaction is associated with the nuclear translocation of the p65-p50 dimer and the activation of the NF-κB signaling pathway. This activation leads to the enhanced transcription of pro-inflammatory cytokines, including IL-1β, IL-6, and IL-8, thereby amplifying the inflammatory response. Within this regulatory framework, TLX1NB plays a pivotal role in mediating TNF-α-induced inflammatory responses in HGFs by modulating MMP8 expression and NF-κB signaling The biological function of TLX1NB was primarily characterized in oncological contexts, where it acts as an oncogene by promoting cancer cell invasion and metastasis via STAT5A signaling [15, 17]. Our work is the first to implicate TLX1NB in a non-neoplastic inflammatory disease, revealing its consistent upregulation in periodontitis gingival tissues and TNF-α-stimulated HGFs. This tissue-specific upregulation aligns with the paradigm that lncRNAs often exert context-dependent functions, a feature also observed in other lncRNAs, such as MALAT1, which regulates metastasis in cancer but osteogenic differentiation in periodontitis [12, 34, 35]. The nuclear localization of TLX1NB provides essential insights into its mechanism of action. Nuclear lncRNAs generally influence gene expression through chromatin remodeling, transcriptional regulation, or by acting as molecular scaffolds [36]. Although we confirmed a direct nuclear interaction between TLX1NB and MMP8, how this interaction leads to changes in MMP8 protein levels remains unclear. Based on established paradigms, TLX1NB may function as a nuclear scaffold to regulate MMP8 at the transcriptional, post-transcriptional, translational, or post-translational levels, as has been demonstrated by other lncRNAs [37]. Nevertheless, the detailed mechanisms by which TLX1NB regulates MMP8 warrant further investigation. Our functional assays further support a pro-inflammatory role for TLX1NB: its knockdown reduced TNF-α-induced secretion of IL-1β, IL-6, and IL-8, while overexpression amplified this inflammatory response. These cytokines are crucial to periodontitis development, promoting extracellular matrix (ECM) breakdown and osteoclast activation [2, 38]. Moreover, TLX1NB affects HGFs fate by promoting apoptosis and inhibiting proliferative effects, likely impairing tissue repair, since HGFs are vital for maintaining the gingival barrier function and ECM stability [39]. Collectively, these findings position TLX1NB as a critical mediator in both inflammatory responses and cellular balance in periodontal tissues. MMP8 is a well-defined biomarker and effector in periodontitis, promoting disease progression through synergistic mechanisms [19, 24]. It directly compromises tissue integrity by degrading type I collagen, the principal structural component of the periodontal ligament [40]. Beyond its structural role, MMP8 acts as a critical regulator of inflammatory signaling [41]. It promotes the release of soluble TNF‑α by cleaving its membrane‑bound precursor [42] and processes chemokines such as IL‑8 to enhance neutrophil infiltration, thereby establishing a pro‑inflammatory positive‑feedback loop that persistently activates the NF‑κB pathway [43]. Our RNA Sequencing analysis identified MMP8 as a target of TLX1NB, and functional validation confirmed that MMP8 knockdown recapitulated the phenotypic effects of TLX1NB silencing, including reduced inflammation, decreased apoptosis, and restored proliferation. This functional convergence suggests that MMP8 is a critical effector of TLX1NB-mediated pathology. Furthermore, the synergistic effect observed upon concurrent knockdown of TLX1NB and MMP8 implies a complex regulatory interaction beyond simple linear signaling. Beyond MMP8, TLX1NB may exert broader effects on the MMP network. Accumulating evidence indicates that certain long non-coding RNAs can coordinately regulate multiple MMP family members, as exemplified by LINC00094, LINC00511, and lncNAP1L6 [44–47]. Notably, MMP-1, MMP-9, and MMP-13 are well-established key mediators of periodontal tissue remodeling and inflammation [48, 49]. Thus, in addition to modulating MMP8, it is conceivable that TLX1NB may also regulate these MMPs critical to periodontitis pathogenesis. Future studies profiling a broader spectrum of MMPs following TLX1NB manipulation will be required to fully delineate its impact on the MMP proteolytic network. The NF-κB signaling axis is broadly accepted as a principal modulator of inflammatory cascades, and its persistent activation is a hallmark of periodontitis [50, 51]. Our data suggest a potential association between TLX1NB, MMP8, and NF-κB activation. In this model, TNF-α upregulates TLX1NB, which is correlated with increased MMP8 expression, and these events coincide with enhanced NF-κB activation and cytokine release, exemplifying the self-amplifying feedforward loops that underpin persistent tissue injury in chronic inflammation [52]. Collectively, our data support a regulatory relationship involving TLX1NB and MMP8 within the inflammatory network of periodontitis. Disrupting this loop at either the TLX1NB or MMP8 level could therefore provide therapeutic benefit, a possibility supported by our dual knockdown experiments, which showed enhanced anti-inflammatory effects. In addition to NF-κB signaling, other inflammatory pathways, such as MAPK and JAK-STAT signaling, may also contribute to TLX1NB-mediated regulation of MMP8, given the complex crosstalk among these cascades in the context of periodontitis [53–56]. Further studies are needed to delineate their relative contributions. Our findings suggest potential clinical applications for TLX1NB and the TLX1NB-MMP8 regulatory network. First, TLX1NB represents a promising candidate for a diagnostic biomarker in periodontitis. Given its significant upregulation in diseased tissues and its correlation with inflammatory cytokine levels, TLX1NB could complement existing biomarkers such as MMP8 and IL-1β in gingival crevicular fluid or saliva [26]. Second, targeting this regulatory module may offer a novel therapeutic strategy. Antisense oligonucleotides (ASOs) or small interfering RNAs (siRNAs) against TLX1NB, or MMP8 inhibitors, could mitigate inflammation and preserve tissue integrity. These approaches have shown promise in preclinical models of inflammatory diseases, with MMP8 inhibitors demonstrating efficacy in reducing periodontal tissue destruction [3, 57, 58]. This study has several limitations. Due to the generally low sequence conservation of lncRNAs [59, 60], TLX1NB lacks orthologs in commonly used laboratory animals, including mice and rats, thus rendering conventional in vivo validation infeasible. Nevertheless, future studies employing gingival organoids may provide an alternative model to further investigate the functional role of TLX1NB. In addition, the in vitro model was limited to TNF-α stimulation, which does not fully recapitulate the complexity of periodontal inflammation. Future studies would benefit from employing more diverse inflammatory stimulation models, such as LPS, combinations of multiple cytokines, or bacterial conditioned medium, to further validate the functional role of TLX1NB. Furthermore, evidence indicates that TLX1NB regulates the phosphorylation of transcription factor STAT5A in colon cancer [15]. Our study also found that the expression of multiple transcription factors was dysregulated after TLX1NB silencing (Appendix Table 7). The detailed molecular mechanism underlying TLX1NB-mediated MMP8 expression remains unclear and will be investigated in future studies. This study implicates lncRNA TLX1NB in periodontitis pathogenesis, suggesting a role for this lncRNA in modulating inflammatory responses and cellular homeostasis in HGFs, potentially through the regulation of MMP8 and engagement with the NF-κB pathway. These observations offer fresh insights into the lncRNA-driven regulatory mechanisms underlying periodontal inflammation and suggest that TLX1NB warrants further exploration as a potential therapeutic target for this common oral disorder. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 (DOCX 504 KB) Supplementary Material 1 (DOCX 504 KB) Supplementary Material 2 (XLSX 8.96 MB) Supplementary Material 2 (XLSX 8.96 MB) Supplementary Material 3 (DOCX 1.34 MB) Supplementary Material 3 (DOCX 1.34 MB) Supplementary Material 4 (DOCX 33.6 KB) Supplementary Material 4 (DOCX 33.6 KB)